MACALUSO, MATTHEW DO; PRESKORN, SHELDON H. MD
MACALUSO and PRESKORN: University of Kansas School of Medicine, Wichita, KS
S.H.P. has worked with over 135 pharmaceutical companies in the United States and throughout the world. Over the past year, he has received grants/research support from or has served as a consultant, on the advisory board, or on the speaker’s bureau for Alkermes, Allergan, BioXcel, Food and Drug Administration, Janssen, National Institute of Mental Health, Merck, Pfizer, and Sunovion. M.M. has conducted clinical trials research as principal investigator for the following pharmaceutical companies over the last 12 months: Acadia, Allergan, AssureRx, Eisai, Lundbeck, Janssen, Naurex/Aptinyx, Neurim, and Suven. All clinical trial and study contracts were with and payments made to the Kansas University Medical Center Research Institute, a research institute affiliated with Kansas University School of Medicine-Wichita (KUSM-W).
Please send correspondence to: Matthew Macaluso, DO, University of Kansas Medical Center, 1010 N. Kansas, Wichita, KS 67217 (e-mail: [email protected]).
doi: 10.1097/PRA.0000000000000345